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The long-term utility of levodopa (l-dopa) treatment
against PD is known to be limited by its subsequent
induction of dyskinesia (l-dopa-induced dyskinesia or
LID). Up to now, few treatment strategies have been iden-
tified to reverse LID and restore l-dopa efficacy in dyski-
netic patients. Among various mechanisms, l-dopa
sensitization ("priming") may play an important role in
the development and maintenance of LID. Disregulation
of dopamine (DA) synthesis, release and clearance of
extracellular DA (due to DA neuronal death and conse-
quent "ectopic" synthesis and release by 5-HT terminals)
is thought to lead to exaggerated fluctuations in the syn-
aptic DA concentrations and consequent neurobiological
alterations during chronic intermittent l-dopa treatment.
These fluctuations, in turn, induce long-term, synaptic
alterations in the striatum and other brain areas compris-
ing the basal ganglia. Previous studies have shown that
long-term sensitization to cocaine can be reversed by
injecting a dopamine receptor agonist, followed by a 5-
HT2 or 5-HT3 antagonist approximately 3.5 hours later
[1,2]. To the extent that cocaine addiction may share sim-
ilar neurobiological mechanisms with LID, it is reasona-
ble to examine a regimen of the DA agonist pergolide
followed by the 5-HT2 antagonist ketanserin at the peak
of acute withdrawal over a treatment period and reverse
sensitization to l-dopa. Based on our previous finding that
this specific drug combination regimen can reverse previ-
ously-established behavioral and molecular markers of
cocaine or methamphetamine sensitization in rats [3], we
determined the striatal mRNA expression profiles associ-
ated with l-dopa-induced dyskinesia in rats and its
reversal by the pergolide-ketanserin regimen. 6-Hydroxy-
dopamine (6-OHDA)-lesioned rats were treated with l-
dopa twice a day for 21 days (days 1 – 21) to induce
abnormal involuntary movements (AIM), a model of LID.
Subsequently, they were treated subcutaneously once a
day for 2 weeks with one of the following. Group A
received pergolide followed by ketanserin; Group B
received pergolide followed by saline; Group C, the con-
trol group, received saline on both occasions. The expres-
sion levels of mRNA were measured for 27,342 genes. The
normalized values provide triplets of positive numbers D
= { (A(n), B(n), C(n)) : n = 1,2,... 27342}. This paper
reports progress in application of new mathematical
methods for exploring this genome-scale gene expression
data. The main geometric idea is to represent the data as a
collection of points in a space that parameterizes congru-
ence classes of triangles in the plane. The distinguishing
advantage of this approach is in extracting significant
(biological) features and patterns of triangle shapes that
are not typically discernible by commonly used statistical
analyses. This method is applied to the data set D, where
a relatively small group of genes are identified and tabu-
lated.
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